Head and neck INI1-deficient carcinoma without primary: a  case report

ConclusionResearch of INI1 deletion should be performed for undifferentiated carcinoma of young patients because of possibilities of molecular therapies such as autophagy inhibitors or proteasome inhibitors could be used in clinical trials.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research